Liver Cancer

Clinical utility of the novel oncological criteria of resectability for advanced hepatocellular carcinoma

Pub Date : 2024-05-16 DOI: 10.1159/000539381 J. Shindoh, Yusuke Kawamura, Keiichi Akahoshi, Masaru Matsumura, S. Okubo, Norio Akuta, Minoru Tanabe, N. Kokudo, Yoshiyuki Suzuki, M. Hashimoto

A Changing Role of TACE in the Era of ICI plus Anti-VEGF/TKI plus TACE: From Total Embolization to Partial Embolization (Immune Boost TACE)

Pub Date : 2024-05-13 DOI: 10.1159/000539301 M. Kudo

Reply to the letter regarding ‘Impact of Bevacizumab Being Skipped due to Adverse Events of Special Interest for Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab: An Exploratory Analysis of the Phase III IMbrave150 Study’

Pub Date : 2024-05-06 DOI: 10.1159/000539205 Masatoshi Kudo, Kaoru Tsuchiya, Tatsuya Yamashita, Hironori Koga, Yuki Nakagawa, Masafumi Ikeda